Key result
The AHA COVID-19 CVD Registry successfully enrolled over 4,000 hospitalized adult patients with active COVID-19 across more than 130 sites within 9 weeks of launch.
Why the study?
In response to the COVID-19 pandemic, there was an urgent need to rapidly develop a resource for shared learning, quality improvement, and research to understand the impact of COVID-19 on cardiovascular disease.
Population
>4000 records of sequential hospitalized adult patients with active COVID-19 disease, regardless of CVD status
Design
Multicenter hospital quality improvement registry
Authors
Loading...
Rapid registry deployment is feasible in pandemics; leaves open whether data will inform COVID-19 CVD practices.
Observational (n=4,000)
Yes
The AHA COVID-19 CVD Registry was rapidly developed to collect data on hospitalized COVID-19 patients to evaluate outcomes and inform best practices.
Alger et al. (2020) conducted an observational in COVID-19 (n=4,000). COVID-19 infection was evaluated. The AHA COVID-19 CVD Registry successfully enrolled over 4,000 hospitalized adult patients with active COVID-19 across more than 130 sites within 9 weeks of launch.